Comparing two versions of a growth hormone medicine
Part of Hormones & metabolism clinical trials.
This study tests if two different ways of making the same growth hormone medicine are equivalent in healthy adults. It might help people who need this treatment by ensuring both versions work the same.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26, and you weigh at least 50 kg.
- You have no significant health issues, as confirmed by physical exams and lab tests.
- You have no serious allergies or allergic conditions, like asthma or hives.
- You have not had major infections, injuries, or surgeries in the past 6 months.
- You have not given blood in the last 3 months and do not plan to donate during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
This study compares two different starting doses of growth hormone to see which works better for children who need it. It may help your child grow taller if they have growth hormone deficiency or short stature.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
Hear when a new Pediatric Growth Hormone Deficiency (PGHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.